ABSI Absci Corp: Sotuvning operatsion marjasi

Absci Corporation - ABSI emitenti grafik logotipi

Global sog'liqni saqlash gigantlari bilan shartnomalarni diversifikatsiya qilish ishlanmalarning xavflarini kamaytiradi, bu esa joriy ko'rsatkichi -9155.40 bo'lgan Absci (ABSI) kompaniyasining operatsion rentabelligini bevosita belgilaydi. AI tomonidan boshqariladigan biologiya sohasidagi vizioner maqomi yangi hamkorlarni jalb qilmoqda, neyron tarmoqlarini o'qitish uchun zaxiralarning rejalashtirilgan taqsimoti esa innovatsion dori vositalarini yaratish davrida Absci moliyaviy barqarorligini ta'minlaydi.

ABSI - Absci Corporation Operatsion foyda normasi 04.07.2022 - 19.11.2026 oraligʻida

Absci (ABSI) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning umumiy tahlili:Absci Corp, ABSI
Absci Bio tayyor mahsulotlari

Operatsion marja soliqlar va foizlar to'lanishidan oldin asosiy operatsiyalardan olingan foydaning umumiy daromadga nisbatan ulushini o'lchaydi. Investorlar operatsion samaradorlikni baholash va kapitalni haddan tashqari qimmat baholangan aktivlardan himoya qilish uchun ushbu ko'rsatkichdan foydalanadilar. Operatsion marja tendentsiyalarini tahlil qilish orqali biznesning barqarorlikka qarab burilish nuqtasini aniqlash mumkin. Absci (ABSI) uchun ushbu metrika raqamli ishlanmalarni kengaytirayotgan paytda uning AI platformasining daromadliligini aks ettiradi. Antitelalarni sog'liqni saqlash gigantlariga litsenziyalash kompaniyaga xarajatlarni tubdan optimallashtirish imkonini beradi.

Asosiy raqobatchilar

Sotuvning operatsion marjasi VEEV|Doximity Network (DOCS) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi HQY (HealthEquity Inc)|Waystar Holding Corp. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik CorVel Corp. CRVL|Operatsion foyda koeffitsiyenti PRVA (Privia Health)|HURN: Sotuvning operatsion marjasi|Certara Corp (CERT) - Sotuvning operatsion marjasi|Omnicell Inc (OMCL) - Operatsion rentabellik|Operatsion foyda bo'yicha marjinallik goodrx.com GDRX|SDGR (Schrodinger Inc) - Operatsion marja|PHR: Operatsion foyda normasi|Operatsion marja OMDA|Evolent - Operatsion foyda bo'yicha sotuv rentabelligi|healthstream.com - Sotuvning operatsion marjasi|Operatsion marja definitivehc.com DH|CCSI - Operatsion rentabellik|Operatsion foyda normasi AGL (agilon health, inc.)|SY: Operatsion marja|Sotuvning operatsion marjasi NRC Health|Operatsion rentabellik Spok Corp|optimizerx.com (OPRX) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi TBRG (TruBridge)|Operatsion faoliyat rentabelligi Simulations Plus Inc|Operatsion marja SOPH (SOPHiA GENETICS SA)|HCAT - Sotuvning operatsion marjasi|CareCloud Corp - Operatsion marja|Operatsion faoliyat rentabelligi Research Solutions RSSS|DLHC (dlhcorp.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi OneMedNet Corp|Operatsion rentabellik Scienture Holdings Inc|HCTI (Healthcare Triangle) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik iSpecimen Corp (ISPC)|Operatsion foyda koeffitsiyenti BFRG|Operatsion rentabellik SCWorx WORX|MSPR - Sotuvning operatsion marjasi|iCoreConnect, Inc. - Operatsion marja|MEDS (TRxADE HEALTH, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|Orgenesis (ORGS) - Operatsion rentabellik|RCM - Operatsion faoliyat rentabelligi|SHCR (Sharecare Inc.) - Operatsion marja|STRM: Operatsion foyda normasi|Operatsion marja SYRA|Sotuvning operatsion marjasi Apollo Medical Holdings, Inc. AMEH|Operatsion rentabellik Model N MODN|Operatsion foyda koeffitsiyenti NXGN (NextGen Healthcare)